nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Toothache—Ethinyl Estradiol—osteoporosis	0.0204	0.0236	CcSEcCtD
Aclidinium—Toothache—Zoledronate—osteoporosis	0.0173	0.02	CcSEcCtD
Aclidinium—Toothache—Estradiol—osteoporosis	0.0133	0.0154	CcSEcCtD
Aclidinium—Osteoarthritis—Etidronic acid—osteoporosis	0.0129	0.0149	CcSEcCtD
Aclidinium—Diabetes mellitus—Raloxifene—osteoporosis	0.0124	0.0143	CcSEcCtD
Aclidinium—Osteoarthritis—Ibandronate—osteoporosis	0.0107	0.0123	CcSEcCtD
Aclidinium—Urinary retention—Ibandronate—osteoporosis	0.0101	0.0117	CcSEcCtD
Aclidinium—Nasopharyngitis—Ibandronate—osteoporosis	0.00954	0.011	CcSEcCtD
Aclidinium—Nasopharyngitis—Calcitriol—osteoporosis	0.00933	0.0108	CcSEcCtD
Aclidinium—Osteoarthritis—Risedronate—osteoporosis	0.00879	0.0102	CcSEcCtD
Aclidinium—Infestation NOS—Estropipate—osteoporosis	0.00857	0.00991	CcSEcCtD
Aclidinium—Infestation—Estropipate—osteoporosis	0.00857	0.00991	CcSEcCtD
Aclidinium—Cardiac failure—Pamidronate—osteoporosis	0.00856	0.00989	CcSEcCtD
Aclidinium—Osteoarthritis—Pamidronate—osteoporosis	0.00835	0.00966	CcSEcCtD
Aclidinium—Infestation NOS—Ibandronate—osteoporosis	0.00822	0.0095	CcSEcCtD
Aclidinium—Infestation—Ibandronate—osteoporosis	0.00822	0.0095	CcSEcCtD
Aclidinium—Sinusitis—Estropipate—osteoporosis	0.00804	0.00929	CcSEcCtD
Aclidinium—Nasopharyngitis—Risedronate—osteoporosis	0.00786	0.00908	CcSEcCtD
Aclidinium—Sinusitis—Raloxifene—osteoporosis	0.00779	0.009	CcSEcCtD
Aclidinium—Rhinitis—Estropipate—osteoporosis	0.00771	0.00891	CcSEcCtD
Aclidinium—Osteoarthritis—Zoledronate—osteoporosis	0.00763	0.00882	CcSEcCtD
Aclidinium—Rhinitis—Raloxifene—osteoporosis	0.00747	0.00864	CcSEcCtD
Aclidinium—Nasopharyngitis—Pamidronate—osteoporosis	0.00747	0.00864	CcSEcCtD
Aclidinium—Urinary tract disorder—Raloxifene—osteoporosis	0.00736	0.00851	CcSEcCtD
Aclidinium—Urethral disorder—Raloxifene—osteoporosis	0.0073	0.00844	CcSEcCtD
Aclidinium—Urinary tract disorder—Ibandronate—osteoporosis	0.00729	0.00842	CcSEcCtD
Aclidinium—Urethral disorder—Ibandronate—osteoporosis	0.00723	0.00836	CcSEcCtD
Aclidinium—Eye disorder—Estropipate—osteoporosis	0.00719	0.00831	CcSEcCtD
Aclidinium—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00695	0.00803	CcSEcCtD
Aclidinium—Infestation—Ethinyl Estradiol—osteoporosis	0.00695	0.00803	CcSEcCtD
Aclidinium—Mediastinal disorder—Estropipate—osteoporosis	0.00693	0.00801	CcSEcCtD
Aclidinium—Eye disorder—Ibandronate—osteoporosis	0.00689	0.00797	CcSEcCtD
Aclidinium—Nasopharyngitis—Zoledronate—osteoporosis	0.00682	0.00789	CcSEcCtD
Aclidinium—Infestation NOS—Risedronate—osteoporosis	0.00677	0.00783	CcSEcCtD
Aclidinium—Infestation—Risedronate—osteoporosis	0.00677	0.00783	CcSEcCtD
Aclidinium—Mediastinal disorder—Ibandronate—osteoporosis	0.00665	0.00769	CcSEcCtD
Aclidinium—Diarrhoea—Calcium Acetate—osteoporosis	0.00658	0.00761	CcSEcCtD
Aclidinium—Sinusitis—Ethinyl Estradiol—osteoporosis	0.00652	0.00753	CcSEcCtD
Aclidinium—Infestation NOS—Pamidronate—osteoporosis	0.00644	0.00744	CcSEcCtD
Aclidinium—Infestation—Pamidronate—osteoporosis	0.00644	0.00744	CcSEcCtD
Aclidinium—Sinusitis—Risedronate—osteoporosis	0.00635	0.00734	CcSEcCtD
Aclidinium—Infection—Etidronic acid—osteoporosis	0.00628	0.00725	CcSEcCtD
Aclidinium—Rhinitis—Ethinyl Estradiol—osteoporosis	0.00625	0.00723	CcSEcCtD
Aclidinium—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.00616	0.00712	CcSEcCtD
Aclidinium—Vomiting—Calcium Acetate—osteoporosis	0.00612	0.00707	CcSEcCtD
Aclidinium—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.00611	0.00707	CcSEcCtD
Aclidinium—Rhinitis—Risedronate—osteoporosis	0.00609	0.00705	CcSEcCtD
Aclidinium—Sinusitis—Pamidronate—osteoporosis	0.00604	0.00698	CcSEcCtD
Aclidinium—Urinary tract disorder—Risedronate—osteoporosis	0.006	0.00694	CcSEcCtD
Aclidinium—Urethral disorder—Risedronate—osteoporosis	0.00596	0.00689	CcSEcCtD
Aclidinium—Osteoarthritis—Estradiol—osteoporosis	0.00588	0.0068	CcSEcCtD
Aclidinium—Infestation NOS—Zoledronate—osteoporosis	0.00588	0.0068	CcSEcCtD
Aclidinium—Infestation—Zoledronate—osteoporosis	0.00588	0.0068	CcSEcCtD
Aclidinium—Cough—Estropipate—osteoporosis	0.00584	0.00675	CcSEcCtD
Aclidinium—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00583	0.00674	CcSEcCtD
Aclidinium—Rhinitis—Pamidronate—osteoporosis	0.00579	0.0067	CcSEcCtD
Aclidinium—Urinary tract disorder—Pamidronate—osteoporosis	0.00571	0.0066	CcSEcCtD
Aclidinium—Eye disorder—Risedronate—osteoporosis	0.00568	0.00657	CcSEcCtD
Aclidinium—Urethral disorder—Pamidronate—osteoporosis	0.00567	0.00655	CcSEcCtD
Aclidinium—Infestation NOS—Conjugated Estrogens—osteoporosis	0.00566	0.00655	CcSEcCtD
Aclidinium—Infestation—Conjugated Estrogens—osteoporosis	0.00566	0.00655	CcSEcCtD
Aclidinium—Cough—Raloxifene—osteoporosis	0.00566	0.00654	CcSEcCtD
Aclidinium—Mediastinal disorder—Risedronate—osteoporosis	0.00548	0.00633	CcSEcCtD
Aclidinium—Infection—Estropipate—osteoporosis	0.00543	0.00628	CcSEcCtD
Aclidinium—Eye disorder—Pamidronate—osteoporosis	0.0054	0.00624	CcSEcCtD
Aclidinium—Nervous system disorder—Estropipate—osteoporosis	0.00536	0.0062	CcSEcCtD
Aclidinium—Infection—Alendronate—osteoporosis	0.00535	0.00618	CcSEcCtD
Aclidinium—Dry mouth—Ibandronate—osteoporosis	0.00535	0.00618	CcSEcCtD
Aclidinium—Sinusitis—Conjugated Estrogens—osteoporosis	0.00531	0.00614	CcSEcCtD
Aclidinium—Infection—Raloxifene—osteoporosis	0.00526	0.00608	CcSEcCtD
Aclidinium—Nasopharyngitis—Estradiol—osteoporosis	0.00526	0.00608	CcSEcCtD
Aclidinium—Dry mouth—Calcitriol—osteoporosis	0.00523	0.00605	CcSEcCtD
Aclidinium—Urinary tract disorder—Zoledronate—osteoporosis	0.00521	0.00603	CcSEcCtD
Aclidinium—Mediastinal disorder—Pamidronate—osteoporosis	0.00521	0.00602	CcSEcCtD
Aclidinium—Infection—Ibandronate—osteoporosis	0.00521	0.00602	CcSEcCtD
Aclidinium—Nervous system disorder—Raloxifene—osteoporosis	0.00519	0.006	CcSEcCtD
Aclidinium—Urethral disorder—Zoledronate—osteoporosis	0.00517	0.00598	CcSEcCtD
Aclidinium—Nervous system disorder—Ibandronate—osteoporosis	0.00514	0.00594	CcSEcCtD
Aclidinium—Rhinitis—Conjugated Estrogens—osteoporosis	0.0051	0.00589	CcSEcCtD
Aclidinium—Eye disorder—Zoledronate—osteoporosis	0.00493	0.0057	CcSEcCtD
Aclidinium—Mediastinal disorder—Zoledronate—osteoporosis	0.00476	0.0055	CcSEcCtD
Aclidinium—Eye disorder—Conjugated Estrogens—osteoporosis	0.00475	0.00549	CcSEcCtD
Aclidinium—Cough—Ethinyl Estradiol—osteoporosis	0.00474	0.00548	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Estropipate—osteoporosis	0.00472	0.00545	CcSEcCtD
Aclidinium—Cough—Risedronate—osteoporosis	0.00462	0.00534	CcSEcCtD
Aclidinium—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00458	0.0053	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00457	0.00528	CcSEcCtD
Aclidinium—Infestation—Estradiol—osteoporosis	0.00453	0.00524	CcSEcCtD
Aclidinium—Infestation NOS—Estradiol—osteoporosis	0.00453	0.00524	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00452	0.00523	CcSEcCtD
Aclidinium—Dry mouth—Risedronate—osteoporosis	0.00441	0.00509	CcSEcCtD
Aclidinium—Infection—Ethinyl Estradiol—osteoporosis	0.0044	0.00509	CcSEcCtD
Aclidinium—Cough—Pamidronate—osteoporosis	0.00439	0.00507	CcSEcCtD
Aclidinium—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00434	0.00502	CcSEcCtD
Aclidinium—Vision blurred—Zoledronate—osteoporosis	0.00433	0.00501	CcSEcCtD
Aclidinium—Diarrhoea—Etidronic acid—osteoporosis	0.00432	0.005	CcSEcCtD
Aclidinium—Infection—Risedronate—osteoporosis	0.00429	0.00496	CcSEcCtD
Aclidinium—Sinusitis—Estradiol—osteoporosis	0.00425	0.00491	CcSEcCtD
Aclidinium—Nervous system disorder—Risedronate—osteoporosis	0.00424	0.0049	CcSEcCtD
Aclidinium—Vision blurred—Conjugated Estrogens—osteoporosis	0.00417	0.00482	CcSEcCtD
Aclidinium—Infection—Pamidronate—osteoporosis	0.00408	0.00472	CcSEcCtD
Aclidinium—Rhinitis—Estradiol—osteoporosis	0.00408	0.00471	CcSEcCtD
Aclidinium—Nervous system disorder—Pamidronate—osteoporosis	0.00403	0.00465	CcSEcCtD
Aclidinium—Urinary tract disorder—Estradiol—osteoporosis	0.00402	0.00464	CcSEcCtD
Aclidinium—Vomiting—Etidronic acid—osteoporosis	0.00402	0.00464	CcSEcCtD
Aclidinium—Cough—Zoledronate—osteoporosis	0.00401	0.00464	CcSEcCtD
Aclidinium—Tachycardia—Pamidronate—osteoporosis	0.00401	0.00463	CcSEcCtD
Aclidinium—Urethral disorder—Estradiol—osteoporosis	0.00399	0.00461	CcSEcCtD
Aclidinium—Headache—Etidronic acid—osteoporosis	0.00396	0.00457	CcSEcCtD
Aclidinium—Cough—Conjugated Estrogens—osteoporosis	0.00386	0.00446	CcSEcCtD
Aclidinium—Dry mouth—Zoledronate—osteoporosis	0.00383	0.00442	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00382	0.00442	CcSEcCtD
Aclidinium—Eye disorder—Estradiol—osteoporosis	0.0038	0.00439	CcSEcCtD
Aclidinium—Diarrhoea—Estropipate—osteoporosis	0.00374	0.00432	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Risedronate—osteoporosis	0.00373	0.00431	CcSEcCtD
Aclidinium—Infection—Zoledronate—osteoporosis	0.00373	0.00431	CcSEcCtD
Aclidinium—Diarrhoea—Alendronate—osteoporosis	0.00368	0.00426	CcSEcCtD
Aclidinium—Nervous system disorder—Zoledronate—osteoporosis	0.00368	0.00425	CcSEcCtD
Aclidinium—Mediastinal disorder—Estradiol—osteoporosis	0.00367	0.00424	CcSEcCtD
Aclidinium—Tachycardia—Zoledronate—osteoporosis	0.00366	0.00423	CcSEcCtD
Aclidinium—Diarrhoea—Raloxifene—osteoporosis	0.00362	0.00419	CcSEcCtD
Aclidinium—Infection—Conjugated Estrogens—osteoporosis	0.00359	0.00415	CcSEcCtD
Aclidinium—Diarrhoea—Ibandronate—osteoporosis	0.00359	0.00415	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00354	0.0041	CcSEcCtD
Aclidinium—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00354	0.00409	CcSEcCtD
Aclidinium—Tachycardia—Conjugated Estrogens—osteoporosis	0.00352	0.00407	CcSEcCtD
Aclidinium—Diarrhoea—Calcitriol—osteoporosis	0.00351	0.00406	CcSEcCtD
Aclidinium—Vomiting—Estropipate—osteoporosis	0.00347	0.00402	CcSEcCtD
Aclidinium—Headache—Estropipate—osteoporosis	0.00342	0.00396	CcSEcCtD
Aclidinium—Vomiting—Alendronate—osteoporosis	0.00342	0.00396	CcSEcCtD
Aclidinium—Headache—Alendronate—osteoporosis	0.00337	0.0039	CcSEcCtD
Aclidinium—Vomiting—Raloxifene—osteoporosis	0.00337	0.00389	CcSEcCtD
Aclidinium—Vomiting—Ibandronate—osteoporosis	0.00333	0.00385	CcSEcCtD
Aclidinium—Headache—Raloxifene—osteoporosis	0.00332	0.00383	CcSEcCtD
Aclidinium—Headache—Ibandronate—osteoporosis	0.00328	0.0038	CcSEcCtD
Aclidinium—Vomiting—Calcitriol—osteoporosis	0.00326	0.00377	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00324	0.00374	CcSEcCtD
Aclidinium—Headache—Calcitriol—osteoporosis	0.00321	0.00372	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00312	0.0036	CcSEcCtD
Aclidinium—Cough—Estradiol—osteoporosis	0.00309	0.00357	CcSEcCtD
Aclidinium—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00303	0.0035	CcSEcCtD
Aclidinium—Diarrhoea—Risedronate—osteoporosis	0.00296	0.00342	CcSEcCtD
Aclidinium—Dry mouth—Estradiol—osteoporosis	0.00295	0.00341	CcSEcCtD
Aclidinium—Infection—Estradiol—osteoporosis	0.00287	0.00332	CcSEcCtD
Aclidinium—Nervous system disorder—Estradiol—osteoporosis	0.00283	0.00328	CcSEcCtD
Aclidinium—Tachycardia—Estradiol—osteoporosis	0.00282	0.00326	CcSEcCtD
Aclidinium—Vomiting—Ethinyl Estradiol—osteoporosis	0.00282	0.00326	CcSEcCtD
Aclidinium—Diarrhoea—Pamidronate—osteoporosis	0.00281	0.00325	CcSEcCtD
Aclidinium—Headache—Ethinyl Estradiol—osteoporosis	0.00278	0.00321	CcSEcCtD
Aclidinium—Vomiting—Risedronate—osteoporosis	0.00275	0.00317	CcSEcCtD
Aclidinium—Headache—Risedronate—osteoporosis	0.00271	0.00313	CcSEcCtD
Aclidinium—Vomiting—Pamidronate—osteoporosis	0.00261	0.00302	CcSEcCtD
Aclidinium—Headache—Pamidronate—osteoporosis	0.00257	0.00297	CcSEcCtD
Aclidinium—Diarrhoea—Zoledronate—osteoporosis	0.00257	0.00297	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Estradiol—osteoporosis	0.0025	0.00288	CcSEcCtD
Aclidinium—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00247	0.00286	CcSEcCtD
Aclidinium—Vomiting—Zoledronate—osteoporosis	0.00238	0.00276	CcSEcCtD
Aclidinium—Headache—Zoledronate—osteoporosis	0.00235	0.00272	CcSEcCtD
Aclidinium—Vomiting—Conjugated Estrogens—osteoporosis	0.0023	0.00265	CcSEcCtD
Aclidinium—Headache—Conjugated Estrogens—osteoporosis	0.00226	0.00262	CcSEcCtD
Aclidinium—Diarrhoea—Estradiol—osteoporosis	0.00198	0.00229	CcSEcCtD
Aclidinium—Vomiting—Estradiol—osteoporosis	0.00184	0.00212	CcSEcCtD
Aclidinium—Headache—Estradiol—osteoporosis	0.00181	0.00209	CcSEcCtD
Aclidinium—CHRM1—GPCR downstream signaling—CNR2—osteoporosis	0.000188	0.0014	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	0.000188	0.00139	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MGLL—osteoporosis	0.000187	0.00138	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000187	0.00138	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	0.000186	0.00138	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—POMC—osteoporosis	0.000185	0.00137	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TLN1—osteoporosis	0.000183	0.00136	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CALCA—osteoporosis	0.000182	0.00135	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—TPI1—osteoporosis	0.000176	0.0013	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TLN1—osteoporosis	0.000175	0.0013	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PTH—osteoporosis	0.000175	0.0013	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PTH—osteoporosis	0.000175	0.0013	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PTH—osteoporosis	0.000173	0.00128	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000171	0.00127	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CNR2—osteoporosis	0.000171	0.00127	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000171	0.00127	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CNR2—osteoporosis	0.00017	0.00126	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000169	0.00125	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CNR2—osteoporosis	0.000169	0.00125	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—P4HB—osteoporosis	0.000165	0.00122	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GAPDH—osteoporosis	0.000162	0.0012	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—WNT1—osteoporosis	0.000161	0.00119	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—WNT1—osteoporosis	0.00016	0.00119	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	0.00016	0.00119	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	0.00016	0.00118	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000159	0.00118	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—IDH2—osteoporosis	0.000159	0.00118	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—WNT1—osteoporosis	0.000159	0.00118	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	0.000158	0.00117	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—P4HB—osteoporosis	0.000158	0.00117	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—RAP1A—osteoporosis	0.000158	0.00117	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MGLL—osteoporosis	0.000157	0.00116	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MGLL—osteoporosis	0.000156	0.00116	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MGLL—osteoporosis	0.000155	0.00115	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PTH—osteoporosis	0.000154	0.00114	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LRP5—osteoporosis	0.000153	0.00113	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LRP5—osteoporosis	0.000152	0.00113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—P4HB—osteoporosis	0.000151	0.00112	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RAP1A—osteoporosis	0.000151	0.00112	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LRP5—osteoporosis	0.000151	0.00112	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CNR2—osteoporosis	0.00015	0.00111	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP27A1—osteoporosis	0.000149	0.00111	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—ADCY5—osteoporosis	0.000149	0.0011	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NFATC1—osteoporosis	0.000147	0.00109	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PTH—osteoporosis	0.000147	0.00109	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LRP6—osteoporosis	0.000146	0.00108	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DKK1—osteoporosis	0.000146	0.00108	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LRP6—osteoporosis	0.000146	0.00108	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	0.000145	0.00108	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ACP5—osteoporosis	0.000145	0.00108	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	0.000145	0.00107	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RAP1A—osteoporosis	0.000145	0.00107	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LRP6—osteoporosis	0.000144	0.00107	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	0.000143	0.00106	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CNR2—osteoporosis	0.000143	0.00106	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000143	0.00106	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	0.000142	0.00106	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NFATC1—osteoporosis	0.000141	0.00105	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	0.000141	0.00104	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—WNT1—osteoporosis	0.000141	0.00104	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	0.00014	0.00104	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DKK1—osteoporosis	0.00014	0.00104	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	0.000139	0.00103	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—LEP—osteoporosis	0.000138	0.00103	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000138	0.00102	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FGA—osteoporosis	0.000137	0.00102	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—TPI1—osteoporosis	0.000135	0.001	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—ADCY5—osteoporosis	0.000135	0.001	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—WNT1—osteoporosis	0.000135	0.000999	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FGA—osteoporosis	0.000131	0.000972	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—POMC—osteoporosis	0.00013	0.000967	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—POMC—osteoporosis	0.00013	0.000964	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	0.000129	0.000958	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—POMC—osteoporosis	0.000129	0.000954	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000128	0.000951	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CALCA—osteoporosis	0.000128	0.000948	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ENO1—osteoporosis	0.000128	0.000946	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CALCA—osteoporosis	0.000128	0.000945	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—BMP2—osteoporosis	0.000127	0.000944	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PTHLH—osteoporosis	0.000127	0.000944	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—P4HB—osteoporosis	0.000127	0.000941	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CALCA—osteoporosis	0.000126	0.000936	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PSMA2—osteoporosis	0.000126	0.000932	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PSMA5—osteoporosis	0.000126	0.000932	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GAPDH—osteoporosis	0.000125	0.000924	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FGB—osteoporosis	0.000125	0.000924	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TLN1—osteoporosis	0.000124	0.000916	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TLN1—osteoporosis	0.000123	0.000913	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PTHLH—osteoporosis	0.000122	0.000904	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—BMP2—osteoporosis	0.000122	0.000904	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TLN1—osteoporosis	0.000122	0.000904	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—RAP1A—osteoporosis	0.000121	0.0009	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PSMA5—osteoporosis	0.00012	0.000892	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PSMA2—osteoporosis	0.00012	0.000892	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FGB—osteoporosis	0.000119	0.000884	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—POMC—osteoporosis	0.000119	0.000882	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PSMA2—osteoporosis	0.000115	0.000854	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PSMA5—osteoporosis	0.000115	0.000854	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—IGF1—osteoporosis	0.000114	0.000848	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CALCA—osteoporosis	0.000112	0.000831	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—POMC—osteoporosis	0.000109	0.00081	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CALCA—osteoporosis	0.000107	0.000796	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—P4HB—osteoporosis	0.000107	0.000789	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—P4HB—osteoporosis	0.000106	0.000787	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—osteoporosis	0.000106	0.000786	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—P4HB—osteoporosis	0.000105	0.000779	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—POMC—osteoporosis	0.000105	0.000776	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTH—osteoporosis	0.000104	0.000768	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTH—osteoporosis	0.000103	0.000766	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTH—osteoporosis	0.000102	0.000758	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP19A1—osteoporosis	0.000102	0.000756	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RAP1A—osteoporosis	0.000102	0.000755	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KL—osteoporosis	0.000102	0.000754	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RAP1A—osteoporosis	0.000101	0.000752	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CNR2—osteoporosis	0.000101	0.000748	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CNR2—osteoporosis	0.000101	0.000746	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000101	0.000745	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RAP1A—osteoporosis	0.000101	0.000745	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	0.0001	0.000743	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.0001	0.000743	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	9.99e-05	0.000741	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CNR2—osteoporosis	9.97e-05	0.000739	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NFATC1—osteoporosis	9.93e-05	0.000736	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—POMC—osteoporosis	9.93e-05	0.000736	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NFATC1—osteoporosis	9.9e-05	0.000734	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	9.89e-05	0.000733	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DKK1—osteoporosis	9.85e-05	0.00073	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DKK1—osteoporosis	9.82e-05	0.000728	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ENO1—osteoporosis	9.81e-05	0.000727	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NFATC1—osteoporosis	9.81e-05	0.000727	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KL—osteoporosis	9.75e-05	0.000723	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DKK1—osteoporosis	9.73e-05	0.000721	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6R—osteoporosis	9.68e-05	0.000718	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PSMA2—osteoporosis	9.67e-05	0.000717	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PSMA5—osteoporosis	9.67e-05	0.000717	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—POMC—osteoporosis	9.51e-05	0.000705	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—WNT1—osteoporosis	9.49e-05	0.000704	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—WNT1—osteoporosis	9.46e-05	0.000701	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—WNT1—osteoporosis	9.37e-05	0.000695	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6R—osteoporosis	9.27e-05	0.000687	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FGA—osteoporosis	9.23e-05	0.000684	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FGA—osteoporosis	9.2e-05	0.000682	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FGA—osteoporosis	9.12e-05	0.000676	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	9.1e-05	0.000675	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	9.07e-05	0.000672	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	8.98e-05	0.000666	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTHLH—osteoporosis	8.58e-05	0.000636	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—BMP2—osteoporosis	8.58e-05	0.000636	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTHLH—osteoporosis	8.56e-05	0.000634	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—BMP2—osteoporosis	8.56e-05	0.000634	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTHLH—osteoporosis	8.47e-05	0.000628	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—BMP2—osteoporosis	8.47e-05	0.000628	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FGB—osteoporosis	8.4e-05	0.000623	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FGB—osteoporosis	8.37e-05	0.000621	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ADCY5—osteoporosis	8.33e-05	0.000618	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GPX1—osteoporosis	8.31e-05	0.000616	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FGB—osteoporosis	8.29e-05	0.000615	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PSMA5—osteoporosis	8.11e-05	0.000601	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PSMA2—osteoporosis	8.11e-05	0.000601	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PSMA2—osteoporosis	8.08e-05	0.000599	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PSMA5—osteoporosis	8.08e-05	0.000599	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PSMA5—osteoporosis	8.01e-05	0.000593	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PSMA2—osteoporosis	8.01e-05	0.000593	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ADCY5—osteoporosis	7.97e-05	0.000591	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP19A1—osteoporosis	7.84e-05	0.000581	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SPP1—osteoporosis	7.71e-05	0.000572	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MTHFR—osteoporosis	7.67e-05	0.000568	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ADCY5—osteoporosis	7.64e-05	0.000566	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CALCA—osteoporosis	7.56e-05	0.00056	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CALCA—osteoporosis	7.53e-05	0.000558	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CALCA—osteoporosis	7.46e-05	0.000553	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SPP1—osteoporosis	7.39e-05	0.000548	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—POMC—osteoporosis	7.37e-05	0.000546	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—POMC—osteoporosis	7.35e-05	0.000545	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—POMC—osteoporosis	7.28e-05	0.000539	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IRS2—osteoporosis	6.98e-05	0.000517	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KL—osteoporosis	6.86e-05	0.000509	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KL—osteoporosis	6.84e-05	0.000507	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—LEP—osteoporosis	6.83e-05	0.000506	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KL—osteoporosis	6.77e-05	0.000502	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—POMC—osteoporosis	6.69e-05	0.000496	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IRS2—osteoporosis	6.68e-05	0.000495	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—POMC—osteoporosis	6.67e-05	0.000495	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—POMC—osteoporosis	6.61e-05	0.00049	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—LEP—osteoporosis	6.54e-05	0.000485	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6R—osteoporosis	6.53e-05	0.000484	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ESR1—osteoporosis	6.52e-05	0.000483	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6R—osteoporosis	6.51e-05	0.000482	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6R—osteoporosis	6.45e-05	0.000478	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ADCY5—osteoporosis	6.41e-05	0.000475	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GPX1—osteoporosis	6.39e-05	0.000473	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ESR1—osteoporosis	6.24e-05	0.000463	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—POMC—osteoporosis	6.13e-05	0.000454	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IRS1—osteoporosis	6.09e-05	0.000451	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MTHFR—osteoporosis	5.89e-05	0.000437	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—POMC—osteoporosis	5.86e-05	0.000435	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IRS1—osteoporosis	5.83e-05	0.000432	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6R—osteoporosis	5.72e-05	0.000424	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF1—osteoporosis	5.64e-05	0.000418	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—POMC—osteoporosis	5.62e-05	0.000416	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6R—osteoporosis	5.48e-05	0.000406	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF1—osteoporosis	5.4e-05	0.0004	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADCY5—osteoporosis	5.38e-05	0.000399	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADCY5—osteoporosis	5.36e-05	0.000397	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADCY5—osteoporosis	5.31e-05	0.000393	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SPP1—osteoporosis	5.2e-05	0.000386	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SPP1—osteoporosis	5.18e-05	0.000384	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SPP1—osteoporosis	5.13e-05	0.000381	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—POMC—osteoporosis	4.71e-05	0.000349	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IRS2—osteoporosis	4.7e-05	0.000349	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IRS2—osteoporosis	4.69e-05	0.000348	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IRS2—osteoporosis	4.64e-05	0.000344	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LEP—osteoporosis	4.6e-05	0.000341	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LEP—osteoporosis	4.59e-05	0.00034	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LEP—osteoporosis	4.54e-05	0.000337	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ESR1—osteoporosis	4.39e-05	0.000326	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ESR1—osteoporosis	4.38e-05	0.000325	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ESR1—osteoporosis	4.34e-05	0.000322	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—osteoporosis	4.31e-05	0.00032	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—osteoporosis	4.13e-05	0.000306	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IRS1—osteoporosis	4.11e-05	0.000304	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IRS1—osteoporosis	4.09e-05	0.000303	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IRS1—osteoporosis	4.05e-05	0.0003	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—POMC—osteoporosis	3.95e-05	0.000293	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—POMC—osteoporosis	3.94e-05	0.000292	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—POMC—osteoporosis	3.9e-05	0.000289	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6R—osteoporosis	3.86e-05	0.000286	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6R—osteoporosis	3.85e-05	0.000285	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6R—osteoporosis	3.81e-05	0.000282	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1—osteoporosis	3.8e-05	0.000282	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1—osteoporosis	3.79e-05	0.000281	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1—osteoporosis	3.75e-05	0.000278	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MYC—osteoporosis	3.39e-05	0.000251	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TGFB1—osteoporosis	3.38e-05	0.000251	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MYC—osteoporosis	3.25e-05	0.000241	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TGFB1—osteoporosis	3.24e-05	0.00024	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—osteoporosis	2.91e-05	0.000216	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—osteoporosis	2.9e-05	0.000215	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.87e-05	0.000213	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—osteoporosis	2.55e-05	0.000189	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—osteoporosis	2.44e-05	0.000181	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MYC—osteoporosis	2.29e-05	0.000169	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFB1—osteoporosis	2.28e-05	0.000169	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MYC—osteoporosis	2.28e-05	0.000169	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFB1—osteoporosis	2.27e-05	0.000168	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MYC—osteoporosis	2.26e-05	0.000167	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFB1—osteoporosis	2.25e-05	0.000167	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—osteoporosis	1.72e-05	0.000127	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—osteoporosis	1.71e-05	0.000127	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—osteoporosis	1.7e-05	0.000126	CbGpPWpGaD
